I’m writing a piece on accidental medication misuse among adults with diabetes—specifically cases where patients are not willfully noncompliant but are still taking medications incorrectly due to confusion, physical limitations, or cognitive issues.
I’m seeking endocrinologists or diabetes specialists to answer a few questions:
1. What are some of the most common medication errors you see in patients with diabetes that aren’t rooted in intentional nonadherence?
2. How do you distinguish between true noncompliance and accidental misuse or misunderstanding?
3. Can you describe how cognitive decline—especially in older adults—affects diabetes medication routines?
4. What role does polypharmacy play in increasing the risk of medication errors in this population?
5. Are there screening tools or conversational strategies you use to assess a patient’s ability to manage their medications?
I will only quote experts who provide permission to be named in the piece.
posted6/2/2025
deadline6/6/2025
processing
published
Recently published by Medscape
Looking to speak with Ob-Gyns, Maternal-Fetal and primary care experts
Seeking U.S.-based experts in pulmonology to comment on innovations in COPD and asthma care
I am working on a Medscape article about new approaches to managing COPD and asthma that go beyond standard inhaler therapy. I am seeking U.S.-based pulmonologists, researchers, or physicians with experience in pulmonary medicine to share insights on emerging strategies in clinical practice and research.
Questions:
What innovations in COPD and asthma care are you seeing beyond pharmacotherapy (e.g., breathing techniques, pulmonary rehab, personalized approaches)?
Are you using or researching personalized oxygen protocols? If so, how do they compare with standard oxygen therapy?
What role do biologic or precision-medicine therapies play in COPD and asthma management today?
What barriers exist in implementing these newer approaches (cost, access, adherence)?
How can primary care providers best incorporate or refer for these innovations?
Looking ahead, what developments are most promising for improving COPD and asthma outcomes over the next 5 years?
Consent Note:
By responding, you consent to being quoted in a Medscape article with attribution. Quotes may be lightly edited for clarity, style, and flow. Please disclose any potential conflicts of interest (such as financial relationships with relevant companies or organizations).